JAGX - Jaguar Health, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2007
Total Revenue4,361.186141.523390.953303.297
Cost of Revenue5,149.867,258.83174.949-
Gross Profit-788.674-7,117.307216.004303.297
Operating Expenses
Research Development--1,672.47215,402.314
Selling General and Administrative10,777.1366,363.2532,618.0667,052.738
Non Recurring----
Others----
Total Operating Expenses15,926.99613,622.0834,465.48722,455.052
Operating Income or Loss-11,565.81-13,480.56-4,074.534-22,151.755
Income from Continuing Operations
Total Other Income/Expenses Net-23,584.046-1,253.228,977.545-3,374.889
Earnings Before Interest and Taxes-11,565.81-13,480.56-4,074.534-22,151.755
Interest Expense-1,209.632-985.549-8,048.674-8,048.674
Income Before Tax-35,149.856-14,733.784,903.011-25,526.644
Income Tax Expense-13,181.242---
Minority Interest----
Net Income From Continuing Ops-21,968.614-14,733.784,903.011-25,526.644
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,968.614-14,733.785,309.161-25,526.644
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,968.614-14,733.785,309.161-26,164.144